This approach was used for the malaria (PfMSP1-19), lymphatic filariasis (Bm14, Bm33, Wb123), stronglyloides (NIE), chikungunya virus (E1), dengue virus (VLP), and (LecA) antigens. February 2015. Filter paper blood samples (= 4,438) were collected from participants in 117 locations and assayed for IgG antibodies on a multiplex bead assay containing 15 different antigens from 11 pathogens: showing the highest rates of seroprevalence. Antibody responses to and lymphatic filariasis were the lowest, with <5% of all samples IgG seropositive to antigens from these pathogens. Clear trends of increasing seropositivity and IgG levels with age were seen for all antigens except those from chikungunya virus and merozoite surface protein 1 (PfMSP1-19) was cloned from isolate 3D7 and expressed as previously described (17, 19, 20). The SAG2A antigen from was cloned from the RH strain and produced recombinantly as described previously (21C23). The production of roundworm recombinant antigens Bm33 and Bm14 have Rabbit polyclonal to ARFIP2 been described previously (24C27). antigen Wb123 was a kind gift from T. Nutman (National Institutes of Health, Bethesda, MD) (28). The NIE antigen (Ss-NIE-1) produced by L3 parasites was recombinantly produced as described previously (29, 30). The chikungunya virus envelope glycoprotein E1 was purchased through CTK Biotech (Porway, CA). The dengue virus serotype 2 virus-like particle was grown and isolated from transfected eukaryotic cell culture as described previously (31). The antigens Pgp3 and CT694 were recombinantly expressed and purified as described previously (32). The recombinant antigen rp17 was purchased by Chembio Diagnostic Systems (Medford, NY) and recombinant TmpA through ViroGen (Boston, MA) and dialyzed overnight before bead coupling as described previously (2). Recombinant enterotoxigenic heat-labile enterotoxin B subunit (ETEC LTB) produced in was purchased from Sigma Aldrich (St. Louis, MO) (33). The LecA recombinant antigen was kindly provided by William Petri, Jr. (University of Virginia, Charlottesville, VA) and Joel Herbein (TechLab, Blacksburg, VA) (34, 35). The recombinant 27-kDa antigen from (Cp23) has been previously described (36, 37). The antigen MBA panel is outlined in Table 1 and Supplementary Table 1. Table 1 Infectious Diseases Represented and Antigens used for Multiplex Serology. spp.Trachoma / Dantrolene ChlamydiaPgp3 spp.Yaws / Syphilisrp17 Bm14 (pH 7.2, 120 g /mL); Wb123 (pH 7.2, 120 g/mL); Bm33 (pH 6.0 with 2M urea, 20 g/mL); Enterotoxigenic (ETEC) heat-labile enterotoxin beta subunit (pH 5, 30 g/mL); Pgp3 pCT03 (pH 7.2, 120 g/mL); CT694 (pH 7.2, 30 g/mL); TmpA (pH 5, 15 g/mL); rp17 (pH Dantrolene 5, 15 g /mL); Dantrolene SAG2A (pH 5, 12.5 g/mL); MSP1 (pH 5, 30 g/mL); NIE (pH 7.2 with 2M urea, 20 g/mL); Cp23 (pH 5, 12.5 g/mL); LecA (pH 5.0, 30 ug/mL). As an internal control to test for non-specific binding or any serum IgG against glutathione-extract to prevent non-specific binding] for a final whole blood dilution of 1 1:400, corresponding to a serum dilution of approximately 1:800 with the assumption of 50% hematocrit in whole blood. This serum dilution in the range of serum dilution previously utilized by our group and found to be able to provide accurate seroestimates for all infectious disease antigens on our multiplex panel. For the MBA, a mix was prepared for all Dantrolene bead regions in 5 mL reagent diluent (PBS, 0.05% Tween20, 0.5% BSA, 0.02% NaN3). Filter bottom plates (Multiscreen 1.2 m, Millipore) were pre-wetted with PBS-T, 50 L bead mix (approximately 1,500 beads/analyte) added to wells and wells washed twice, and beads incubated with the sample in duplicate for 1.5 h under gentle shaking. Secondary antibodies tagged with biotin (1:500 monoclonal mouse anti-human total IgG (Southern Biotech); 1:625 monoclonal mouse anti-human IgG4 (Southern Biotech) were incubated with the beads for 45 min, and subsequent incubation with streptavidin-phycoerythrin (1:200, Invitrogen) for 30 min. Plates had a final wash incubation with reagent diluent for 30 min and were read on a Bio-Plex Dantrolene 200 machine to generate the median fluorescence intensity (MFI) signal for 50 beads/analyte. Background (bg) MFI was generated from blank wells containing only sample diluent, and this value was subtracted from each antigen’s raw MFI to give an MFI-bg. The mean of MFI-bg values from duplicate wells was used for analysis, though previous studies from our group and others have also shown high reproducibility for MBAs when only.